LCTX
Lineage Cell Therapeutics Inc

7,687
Loading...
Loading...
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
77

Frequently Asked Questions

What is Market Cap of Lineage Cell Therapeutics Inc?
What is the 52-week high for Lineage Cell Therapeutics Inc?
What is the 52-week low for Lineage Cell Therapeutics Inc?
What is Lineage Cell Therapeutics Inc stock price today?
What was Lineage Cell Therapeutics Inc stock price yesterday?
What is the PE ratio of Lineage Cell Therapeutics Inc?
What is the Price-to-Book ratio of Lineage Cell Therapeutics Inc?
What is the 50-day moving average of Lineage Cell Therapeutics Inc?
How many employess does Lineage Cell Therapeutics Inc has?

Latest LCTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.